Recommended Protocol for the Study of the Ex Vivo Biological Effects of Virus-Inactivated Plasma Concentrates in Patients with von Willebrand Disease

This publication has 15 references indexed in Scilit:

• In vitro and in vivo characterization of a high-purity, solvent/detergent-treated factor VIII concentrate: Evidence for its therapeutic efficacy in von Willebrand's disease
  European Journal of Haematology, 2009
• Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease
  Blood Reviews, 1991
• Clinical and laboratory evaluation of the treatment of von Willebrand's disease patients with heat-treated factor VIII concentrate (BPL 8Y)
  British Journal of Haematology, 1990
• Treatment of von willebrand's disease and hypofibrinogenemia with single donor cryoprecipitate from plasma exchange donation
  American Journal of Hematology, 1989
• VIRUCIDAL TREATMENT OF CLOTTING FACTOR CONCENTRATES
  The Lancet, 1988
• Hemostatic effect of a heat-treated factor VIII concentrate (Haemate P) in von Willebrand's disease
  Annals of Hematology, 1988
• Biochemical and in vivo properties of commercial virus‐inactivated factor VIII concentrates
  European Journal of Haematology, 1988
• The use of heat-treated factor VIII-concentrates in von willebrand's disease
  Annals of Hematology, 1985
• Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion
  The American Journal of Medicine, 1977
• Immunoradiometric Assay of Factor VIII Related Antigen, with Observations in 32 Patients with von Willebrand's Disease
  British Journal of Haematology, 1976